Treatment of malignant gliomas in elderly patients: A concise overview of the literature

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Farina, Patrizia ^a   Lombardi, Giuseppe ^a   Bergo, Eleonora ^a   Roma, Anna ^a   Zagonel, Vittorina ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; FOTEMUSTINE; ISOCITRATE DEHYDROGENASE 1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; STEROID; TEMOZOLOMIDE;

ALLELE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; DELIRIUM; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DNA METHYLATION; DOSE DENSIFICATION; EPIDEMIOLOGY; FOLLOW UP; GLIOBLASTOMA; HEADACHE; HEMIPARESIS; HUMAN; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; INTRACRANIAL HYPERTENSION; KARNOFSKY PERFORMANCE STATUS; MENTAL DETERIORATION; NEUROIMAGING; NEUROSURGERY; NEUROTOXICITY; OVERALL SURVIVAL; PATIENT CARE; PILOCYTIC ASTROCYTOMA; PROGRESSION FREE SURVIVAL; PYROSEQUENCING; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; REVIEW; AGED; BRAIN NEOPLASMS; GENETICS; GLIOMA; PATHOPHYSIOLOGY; PROGNOSIS;

AGED; BRAIN NEOPLASMS; COGNITION; GLIOMA; HUMANS; PROGNOSIS; QUALITY OF LIFE;

EID: 84901270393     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/734281     Document Type: Review

References (38)

1. Greig N. H., Ries L. G., Yancik R., Rapoport S. I., Increasing annual incidence of primary malignant brain tumors in the elderly. Journal of the National Cancer Institute 1990 82 20 1621 1624 2-s2.0-0025183905 (Pubitemid 20345298)
2. Iwamoto F. M., Reiner A. S., Panageas K. S., Elkin E. B., Abrey L. E., Patterns of care in elderly glioblastoma patients. Annals of Neurology 2008 64 6 628 634 2-s2.0-58149265348 10.1002/ana.21521
3. Tabouret E., Tassy L., Chinot O., High-grade glioma in elderly patients: can the oncogeriatrician help? Clinical Interventions in Aging 2013 8 1617 1624
4. Ricard D., Idbaih A., Ducray F., Lahutte M., Hoang-Xuan K., Delattre J.-Y., Primary brain tumours in adults. The Lancet 2012 379 1984 1996 2-s2.0-84859640760 10.1016/S0140-6736(11)61346-9
5. Ohgaki H., Kleihues P., Epidemiology and etiology of gliomas. Acta Neuropathologica 2005 109 1 93 108 2-s2.0-14244265590 10.1007/s00401-005-0991-y (Pubitemid 40287792)
6. van den Bent M. J., Brandes A. A., Taphoorn M. J., Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. Journal of Clinical Oncology 2013 31 344 350
7. Chakrabarti I., Cockburn M., Cozen W., Wang Y.-P., Preston-Martin S., A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer 2005 104 12 2798 2806 2-s2.0-29144530536 10.1002/cncr.21539 (Pubitemid 41798291)
8. Iwamoto F. M., Cooper A. R., Reiner A. S., Nayak L., Abrey L. E., Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center experience (1997-2007). Cancer 2009 115 16 3758 3766 2-s2.0-68549111220 10.1002/cncr.24413
9. Cairncross G., Wang M., Shaw E., Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. Journal of Clinical Oncology 2013 31 337 343
10. Reifenberger G., Hentschel B., Felsberg J., Schackert G., Simon M., Schnell O., Westphal M., Wick W., Pietsch T., Loeffler M., Weller M., Predictive impact of MGMT promoter methylation in glioblastoma of the elderly. International Journal of Cancer 2012 131 1342 1350 2-s2.0-84855612945 10.1002/ijc.27385
11. Wiestler B., Claus R., Hartlieb S. A., Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective. Neuro-Oncology 2013 15 1017 1026
12. Kita D., Ciernik I. F., Vaccarella S., Franceschi S., Kleihues P., Lütolf U. M., Ohgaki H., Age as a predictive factor in glioblastomas: population-based study. Neuroepidemiology 2009 33 1 17 22 2-s2.0-62949099350 10.1159/000210017
13. Barker C. A., Chang M., Chou J. F., Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma. Journal of Neuro-Oncology 2012 109 391 397
14. Mohan D. S., Suh J. H., Phan J. L., Kupelian P. A., Cohen B. H., Barnett G. H., Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. International Journal of Radiation Oncology Biology Physics 1998 42 5 981 987 2-s2.0-0032411553 10.1016/S0360-3016(98)00296-X (Pubitemid 29004138)
15. Minniti G., Sanctis V., Muni R., Rasio D., Lanzetta G., Bozzao A., Osti M. F., Salvati M., Valeriani M., Cantore G. P., Maurizi Enrici R., Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. Journal of Neuro-Oncology 2009 91 1 95 100 2-s2.0-57049176929 10.1007/s11060-008-9689-z
16. Nguyen L. T., Touch S., Nehme-Schuster H., Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy. Cancers 2013 5 1177 1198
17. Villà S., Viñolas N., Verger E., Yaya R., Martínez A., Gil M., Moreno V., Caral L., Graus F., Efficacy of radiotherapy for malignant gliomas in elderly patients. International Journal of Radiation Oncology Biology Physics 1998 42 5 977 980 2-s2.0-0345196626 10.1016/S0360-3016(98)00356-3 (Pubitemid 29004137)
18. Saito K., Mukasa A., Narita Y., Toxicity and outcome of radiotherapy with concomitant and adjuvant temozolomide in elderly patients with glioblastoma: a retrospective study. Neurologia Medico-Chirurgica 2013 10.2176/nmc.oa2012-0441
19. Minniti G., Sanctis V., Muni R., Filippone F., Bozzao A., Valeriani M., Osti M. F., De Paula U., Lanzetta G., Tombolini V., Maurizi Enrici R., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. Journal of Neuro-Oncology 2008 88 1 97 103 2-s2.0-42349090207 10.1007/s11060-008-9538-0
20. Cao J. Q., Fisher B. J., Bauman G. S., Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience. Journal of Neuro-Oncology 2012 107 395 405
21. Chinot O.-L., Barrle M., Frauger E., Dufour H., Figarella-Branger D., Palmari J., Braguer D., Hoang-Xuan K., Moktari K., Peragut J.-C. C., Martin P.-M. M., Grisoli F., Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 2004 100 10 2208 2214 2-s2.0-1042297227 10.1002/cncr.20224 (Pubitemid 38580342)
22. Cao J. Q., Fisher B. J., Bauman G. S., Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience. Journal of Neuro-Oncology 2012 107 395 405
23. Uzuka T., Asano K., Sasajima T., Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study. Journal of Neuro-Oncology 2014 116 299 306
24. Yin A. A., Cai S., Dong Y., A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients. Journal of Neuro-Oncology 2014 116 315 324 10.1007/s11060-013-1294-0
25. Malmstrom A., Gronberg B. H., Marosi C., Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. The Lancet Oncology 2012 13 916 926
26. Wick W., Platten M., Meisner C., Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. The Lancet Oncology 2012 13 707 715
27. Pérez-Larraya J. G., Ducray F., Chinot O., Catry-Thomas I., Taillandier L., Guillamo J.-S., Campello C., Monjour A., Cartalat-Carel S., Barrie M., Huchet A., Beauchesne P., Matta M., Mokhtari K., Tanguy M.-L., Honnorat J., Delattre J.-Y., Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. Journal of Clinical Oncology 2011 29 22 3050 3055 2-s2.0-80051659072 10.1200/JCO.2011.34.8086
28. Santoni M., Scoccianti S., Lolli I., Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma. Journal of Neuro-Oncology 2013 113 397 401
29. Omuro A., DeAngelis L. M., Glioblastoma and other malignant gliomas: a clinical review. JAMA 2013 310 1842 1850
30. Kerkhof M., Dielemans J. C., van Breemen M. S., Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro-Oncology 2013 15 961 967
31. De Angelis L., Posner J. B., Neurologic Complications of Cancer. Side Effects of Chemotherapy 2009 New York, NY, USA Oxford University Press
32. Brown P. D., Decker P. A., Rummans T. A., Clark M. M., Frost M. H., Ballman K. V., Arusell R. M., Buckner J. C., A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life. American Journal of Clinical Oncology 2008 31 2 163 168 2-s2.0-42049103960 10.1097/COC.0b013e318149f1d3 (Pubitemid 351519168)
33. Minniti G., Scaringi C., Baldoni A., Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide. International Journal of Radiation Oncology, Biology, Physics 2013 86 285 291
34. Monfardini S., Ferrucci L., Fratino L., Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer 1996 77 395 401 (Pubitemid 26023359)
35. Chiu L., Chiu N., Zeng L., Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30. Expert Review of Pharmacoeconomics & Outcomes Research 2012 12 831 837
36. Taphoorn M. J. B., Claassens L., Aaronson N. K., Coens C., Mauer M., Osoba D., Stupp R., Mirimanoff R. O., van den Bent M. J., Bottomley A., An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. European Journal of Cancer 2010 46 6 1033 1040 2-s2.0-77949489275 10.1016/j.ejca.2010.01.012
37. Repetto L., Fratino L., Audisio R. A., Venturino A., Gianni W., Vercelli M., Parodi S., Dal Lago D., Gioia F., Monfardini S., Aapro M. S., Serraino D., Zagonel V., Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology study. Journal of Clinical Oncology 2002 20 2 494 502 2-s2.0-0037080281 10.1200/JCO.20.2.494 (Pubitemid 34072534)
38. Lombardi G., Bellu L., Berti F., Efficacy and safety of radiotherapy plus temozolomide in elderly patients with glioblastoma. Journal of Clinical Oncology 2013 31 2043